维普期刊资源整合服务平台（V6.5）

206篇 您的检索式：作者名="Shiffman ML"

选中清除导出查看参考文献查看引证文献引用追踪共11页首页上一页第1页下一页末页 /11 跳转

	题名	作者	年代	出处	被引量
1	Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection显示文摘	Fried MW Shiffman ML Reddy KR		New England Journal of Medicine0，，：	4
2	Impact of peginterferon maintenance therapy on the risk of developing hepatocellular carcinoma in patients with chron- ic hepatitis C virus 显示文摘	Shiffman ML	2010	Oncology2010，78，1：	1
3	Peginterferon alpha-2b or alfa-2a with ribavirin for treatment of hepatitis C infection 显示文摘	McHutchison JG Lawitz EJ Shiffman ML	2009	N Engl J Med2009，361，6：	1
4	Peginterfer- on alfa -2a plus ribavirin for chronic hepatitis Cvirus infection 显示文摘	FRIED MW SHIFFMAN ML REDDY KR	2002	N EnglJ Med2002，347，13：	1
5	Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection显示文摘	Fried MW Shiffman ML Reddy KR	2002	N Engl J Med2002，347，：	1
6	Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment显示文摘	Shiffman ML Di Bisceglie AM Lindsay KL		0，，：	1
7	Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection显示文摘	Fried MW Shiffman ML Reddy KR		0，，13：	1
8	Retreating chronic hepatitis C with daily interferon alfacon-1/ribavirin after nonresponse to pegylated interferon/ribavirin:DIRECT results显示文摘	Bacon BR Shiffman ML Mendes F	2009	Hepatology2009，49，6：	1
9	Peginterferon al- fa-2b or alfa-2a with ribavirin for treatment of hepatitis C infec- tion显示文摘	McHutchison JG Lawitz E J Shiffman ML	2009	N Engl J Med2009，361，6：	1
10	Rate of progression of hepatic fibrosis in patients with chronic hepatitis C:results from the HALT-C Trial显示文摘	Hoefs JC Shiffman ML Goodman ZD		0，，：	1
11	Prophylaxsis against recarrance of hepatitis B virus after liver transplantation : a retrospective analysis spanning 20 years 显示文摘	Yilmaz N Shiffman ML Todd Stravitz R	2008	Liver Int2008，28，1：	1
12	The role of transjugular intrahepatic portosystemic shunt for treatment of portal hypertension and its complications:a conference sponsored by the National Digestive Diseases Advisory Board显示文摘	Shiffman ML Jeffers L Hoofnagle JH	1995	Hepatology1995，22，15：	1
13	Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection显示文摘	Fried MW Shiffman ML Reddy KR	2002	N Engl J Med2002，347，13：	1
14	Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C显示文摘	McHutchison JG Dusheiko G Shiffman ML	2007	N Engl J Med2007，357，22：	1
15	Retreating chronic hepa- titis C with daily interferon alfacon-1/ribavirin after nonresponse to pegylated interferon/ribavirin: DIRECT results 显示文摘	Bacon BR Shiffman ML Mendes F	2009	Hepatology2009，49，6：	1
16	Twelve weeks of follow-up is sufficient for the determination of sustained virologic response in patients treated with in- terferon alpha for chronic hepatitis C 显示文摘	Zeuzem S Heathcote Shiffman ML	2003	J Hepatol2003，39，1：	1
17	Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection 显示文摘	FRIED MW SHIFFMAN ML REDDY K	2002	N Engl J Med2002，347，：	1
18	Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis显示文摘	Heathcote EJ Shiffman ML Cooksley WG	2000	N Engl J Meal2000，343，23：	1
19	Predicting sus-tained virological responses in chronic hepatitis C patients trea-ted with peginterferon alfa -2a (40 KD)/ribavirin显示文摘	FERENCI P FRIED MW SHIFFMAN ML	2005	J Hepa-tol2005，43，3：	1
20	Peg, interferon alfa-2a and ribavirin for 16 or24 weeks in HCV genotype 2 or3显示文摘	Shiffman ML Suter F Bacon BR	2007	N Engl J Med2007，357，2：	1

返回顶部每页显示：

共11页首页上一页第1页下一页末页 /11 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示